Guru Ownership Trend
Guru Analysis for Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $138.77 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.07 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 143.1%. Conversely, Ken Fisher reduced exposure by 18.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Kiniksa Pharmaceuticals International, plc (KNSA)
Major holders include Steven Cohen ($40.92 M), Cliff Asness ($32.53 M), Ken Fisher ($24.16 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.48 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.07 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited KNSA. The total reported sell value was $13.88 M.
Yes, 0 managers opened new positions in KNSA, and 2 increased their existing holdings. The total reported buy value was $11.81 M.